cas 63460-47-9|| where to buy 2-(4-iodopentyl)isoindole-1,3-dione

Nombre del producto:2-(4-iodopentyl)isoindole-1,3-dione

IUPAC Name:2-(4-iodopentyl)-2,3-dihydro-1H-isoindole-1,3-dione

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 63460-47-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :63460-47-9; Fórmula molecular:C13H14INO2; Punto de fusión:-; Código de sonrisas:O=C1N(CCCC(I)C)C(C2=C1C=CC=C2)=O; Densidad:

: Número de catálogo:CM341453; Peso molecular:343.16; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Tafenoquine; 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.